{"id":"NCT00069823","sponsor":"Johns Hopkins Bloomberg School of Public Health","briefTitle":"Study of Acid Reflux in Asthma","officialTitle":"The Study of Acid Reflux in Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-09","primaryCompletion":"2008-05","completion":"2008-05","firstPosted":"2003-10-03","resultsPosted":"2012-10-19","lastUpdate":"2012-12-19"},"enrollment":403,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma","Lung Diseases","Lung Diseases, Obstructive"],"interventions":[{"type":"DRUG","name":"Esomeprazole","otherNames":["Nexium"]},{"type":"DRUG","name":"Placebo proton pump inhibitor","otherNames":[]}],"arms":[{"label":"Esomeprazole","type":"EXPERIMENTAL"},{"label":"Placebo for esomeprazoe","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if subjects with symptomatic asthma who are assigned to treatment with a proton pump inhibitor (PPI) drug such as Nexium have fewer asthma attacks than similar subjects assigned to placebo treatment.","primaryOutcome":{"measure":"Episodes of Poor Asthma Control (EPAC) From Diary Cards, According to Definition That Did Not Include Use of Beta-agonists as a Criterion","timeFrame":"Baseline to 24 Weeks","effectByArm":[{"arm":"Placebo","deltaMin":2.3,"sd":null},{"arm":"Esomeprazole","deltaMin":2.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.66"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":12},"locations":{"siteCount":20,"countries":["United States"]},"refs":{"pmids":["37536444","23026499","22885561","19661245","19357404"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":199},"commonTop":[]}}